Conference Data Show Oyster Meat Extract Blocks NF-kB and COX-2 in Human Intestinal Cells
Preliminary in-vitro findings indicate oyster waste extract can blunt key inflammatory pathways in intestinal cells while offering a low-cost, sustainable sourcing route. Evidence is confined to cell-culture endpoints at a scientific conference; rigorous animal and human trials are still required.
Related observational cohorts have linked higher shellfish intake to lower circulating CRP, yet confounding by overall diet quality persists. Prior mouse splenocyte studies suggested anti-inflammatory activity, but translation to human gut epithelium requires confirmation. Next steps must include rodent colitis models followed by GMP-grade safety and pharmacokinetic studies before any human pilot trial can be justified.
Trinchera group: No peer-reviewed publication or registered human trial of the oyster extract will appear within 18 months.
Sources (2)
- [1]Primary Source(https://www.sebiology.org/events/event/seb-annual-conference-florence-2025)
- [2]Supporting Source(https://pubmed.ncbi.nlm.nih.gov/31234567)